Eugene M Langan 3rd
Overview
Explore the profile of Eugene M Langan 3rd including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
320
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sticco A, Gandhi S, Knoedler B, Marston G, Ewing A, Langan 3rd E, et al.
Ann Vasc Surg
. 2020 Aug;
70:252-257.
PMID: 32768545
Background: There is no consensus on the treatment of blunt vertebral artery injuries, and studies are limited to small case series. We assessed the natural history and current management of...
2.
Betala J, Bae S, Langan 3rd E, LaBerge M, Lee J
Nanomedicine (Lond)
. 2020 Apr;
15(12):1205-1220.
PMID: 32340540
To develop poly(lactide-co-glycolide)-graft-polyethylenimine (PgP) as a dual drug-delivery carrier for sirolimus (SR) and heparin (Hep) to inhibit restenosis after balloon angioplasty. SR was loaded in the hydrophobic core and negatively...
3.
Chawla V, Simionescu A, Langan 3rd E, LaBerge M
Ann Vasc Surg
. 2016 Apr;
34:212-26.
PMID: 27126714
Background: In this study, we subjected vascular smooth muscle cells (VSMC) to acute and chronic high glucose conditions under physiologically relevant levels of cyclic strain and low wall shear forces...
4.
Hale A, Twomey K, Ewing J, Langan 3rd E, Cull D, Gray B
Vasc Med
. 2016 Feb;
21(3):217-22.
PMID: 26850115
Sarcopenia, also known as a reduction of skeletal muscle mass, is a patient-specific risk factor for vascular and cancer patients. However, there are no data on abdominal aortic aneurysm (AAA)...
5.
Cull D, Langan 3rd E, Taylor S, Carsten 3rd C, Tong A, Johnson B
J Vasc Surg
. 2013 Oct;
58(4):1123-8.
PMID: 24075111
A number of surgery practice models have been developed to address general and trauma surgeon workforce shortages and on-call issues and to improve surgeon satisfaction. These include the creation of...
6.
Gray B, Langan 3rd E, Manos G, Bair L, Lysak S
Ann Vasc Surg
. 2012 Jun;
26(5):734-8.
PMID: 22664284
We present two cases of ascending aortic pseudoaneurysm exclusion with off-the-shelf aortic stent grafts. The right common carotid artery was used for access to facilitate graft delivery. Control of graft...
7.
Taneja V, Vertegel A, Langan 3rd E, LaBerge M
Ann Vasc Surg
. 2011 Jul;
25(5):675-85.
PMID: 21724105
The phenotypic shift of smooth muscle cells (SMCs) from contractile to synthetic phenotype after endovascular stenting has been deemed to be the predominant cause of restenosis. Although substrate topography has...
8.
Taylor S, Johnson B, Samies N, Rawlinson R, Williamson L, Davis S, et al.
J Am Coll Surg
. 2011 Apr;
212(4):532-45.
PMID: 21463785
Background: For patients with diabetic neuropathic foot ulceration, the current treatment paradigm is heavily weighted toward limb revascularization; aligning incentives to perform more surgery and less ulcer management/prevention. Our purpose...
9.
Gray B, Grant A, Kalbaugh C, Blackhurst D, Langan 3rd E, Taylor S, et al.
Ann Vasc Surg
. 2010 Jan;
24(3):349-59.
PMID: 20045628
Background: Most patients with critical limb ischemia (CLI) have multilevel infrainguinal peripheral arterial disease (M-PAD). One-third of CLI patients will have isolated tibial disease (ITD). The treatments for multilevel disease...
10.
Acampora K, Nagatomi J, Langan 3rd E, LaBerge M
Ann Vasc Surg
. 2009 Sep;
24(1):116-26.
PMID: 19781909
Restenosis remains a common problem following balloon angioplasty, and it has been speculated that changes in the mechanical environment due to endovascular interventions are correlated with shifts in smooth muscle...